Our research results first showed inhibition of TGF‐β receptor type I/II and phosphorylation of Smad3 suppresses proliferation of CEA‐regulated oncolytic adenovirus CD55 in HCC (Fig. S1). This evidence concerns the gene SMAD3 and hepatocellular carcinoma.